Search Results 1511-1520 of 74765 for Molecular
The division is supported by full-service laboratories in Histology, Cytopathology, Immunohistochemistry, Molecular Anatomic Pathology, Molecular Genetics, ...
Molecular predictors or response. Using next-generation sequencing technologies, Dr. Dowdy and his team identified subtypes of ovarian cancer more likely to ...
Franklyn Prendergast, M.D., Ph.D., emeritus professor of biochemistry, molecular biology, and pharmacology at Mayo Clinic College of Medicine and Science, also ...
1993. PhD - Molecular BiologyUniversity of Pennsylvania. 1985. BA ... Distinguished Service Award, Molecular OrthopaedicsUniversity of Pennsylvania Health System.
... molecular remission" for at least two years. Molecular remission means the gene that causes CML cannot be found in the patient's blood or bone marrow.
Imagine a future where healthcare is tailored precisely for you, right down to the molecules deep inside your cells. ... RegenBio Summit: Could a molecular ...
The findings translate into potential new targets for therapeutics, and his group now is testing small molecules that may block these toxic processes.
The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. For more ...
Cliby's team, along with experts in radiology and molecular genetics, study key clinical characteristics of specific molecular subtypes of ovarian cancer.
Molecular breast imaging (MBI). Over the last 10 years, Dr. · Breast density. Breast density is the single most important factor in the failure of mammography to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.